- Home
- GTLS vs PCVX Comparison
GTLS vs PCVX Comparison
Compare GTLS & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GTLS | PCVX |
|---|---|---|
| Founded | 1859 | 2013 |
| Country | United States | United States |
| Employees | 11777 | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 8.6B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | GTLS | PCVX |
|---|---|---|
| Price | $207.24 | $54.36 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $205.67 | $88.25 |
| AVG Volume (30 Days) | 1.0M | ★ 1.3M |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.31 | N/A |
| Revenue Next Year | $5.89 | N/A |
| P/E Ratio | $240.25 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $141.47 | $29.00 |
| 52 Week High | $208.51 | $65.00 |
Technical Indicators
Market Signals| Indicator | GTLS | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 44.35 | 41.21 |
| Support Level | $206.51 | $52.04 |
| Resistance Level | $207.59 | $56.04 |
| Average True Range (ATR) | 0.39 | 2.66 |
| MACD | -0.07 | -0.59 |
| Stochastic Oscillator | 23.42 | 44.02 |
Price Performance
Historical ComparisonAbout GTLS Chart Industries Inc.
Chart Industries provides a variety of cryogenic equipment for storage, distribution, and other processes within the industrial gas and liquefied natural gas industries. It also provides natural gas processing solutions for the natural gas industry and specialty products that serve a variety of spaces, including hydrogen, biofuels, cannabis, and water treatment. The firm acquired Howden in a significant deal in early 2023, roughly doubling the size of the company. It plans to merge with Flowserve by the end of 2025.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.